NeuroScientific begins cell therapy manufacturing transfer to Q-Gen - Australian Manufacturing

NeuroScientific partners with Q-Gen Cell manufacturer - Manufacturers' Monthly

Image: wacomka/stock.adobe.comNeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has commenced the transfer of its patented mesenchymal stromal cell manufacturing process to Q-Gen Cell Therapeutics, part of the QIMR Berghofer Medical Research Institute in Brisbane. The move marks a significant milestone for the company, which is preparing for further clinical trials and exploring commercial pathways for its proprietary cell therapy platform, Stem…

NeuroScientific begins cell therapy manufacturing transfer to Q-Gen - Australian Manufacturing

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has commenced the transfer of its patented cell manufacturing process to Q-Gen Cell Therapeutics, a move the company says is a key step in advancing its clinical development and commercialisation plans.